维普中文期刊产品整合服务
48篇 您的检索式:作者名="KRAMAR M A"
    题名 作者 年代 出处 被引量
1Estrogen receptor beta (ER beta) level not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer显示文摘Esslimani-Sahla M Simony-Lafontaine J Kramar A 2004Clin Cancer Res2004,10,17:1
2Individual5-FU dose adaptation in metastatic colorectalcancer: results of a phase II study using abimonthly pharmacokinetically intensified LV5FU2regimen显示文摘YCHOU M DUFFOURJ KRAMAR A etai 2003Cancer Chemother Pharmacol2003,52,4:1
3Comparison of serum CYFRA21-1 and SCC in the diagnosis of squamous cell esophageal carcinoma显示文摘Ychou M Khemissa-Akouz F Kramar A 2001Bull Cancer2001,88,:1
4A comparison of serum Cyfra 21-1 and SCC AG in the diagnosis of squamous cell esophageal carcinoma 显示文摘Ychou M Khemissa-Akouz F Kramar A 2001Bull Cancer2001,88,10:1
5Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site显示文摘Culine S Kramar A Saghatchian M 2002J Clin Oncol2002,20,24:1
6Clinical significance and prognostic value of CA72-4 compared with TAG72 and CA19-9 in patients with gastric cancer 显示文摘Ychou M Duffour J Kramar A 2000Dis Markers2000,16,34:1
7Clinical significance and prognostic value of CA72 -4 compared with CEA and CA19 -9 in patients with gastric cancer显示文摘M Ychou J Duffour A Kramar 2000Disease Markers2000,16,3:1
8Plasma-replacement technology of ETC-ignition of powder charges in high-velocity launchers显示文摘Sinyaev S V Kramar M A Kulpin V I 2007IEEE Transactions on Magnetics2007,43,1:1
9Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer显示文摘YCHOU M DUFFOUR J KRAMAR A 2000Dis-Markers2000,16,34:1
10Estrogen receptor beta(ERbeta) level but not its ERbetaex variant helps to predict tamoxifen resistance in breast canc- er显示文摘Esslimani-Sahla M Simony-Lafoniaine J Kramar A 2004Clin Cancer Res2004,10,17:1
11Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer 显示文摘Ychou M Duffour J Kramar A 2000Dis Markers2000,16,34:1
12Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastriccancer显示文摘Ychou M Duffour J Kramar A 2000Dis Markers2000,16,:1
13Estrogen receptor beta(ER beta)level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer显示文摘Esslimani-Sahla M Simony-Lafontaine J Kramar A 2004Clin Cancer Res2004,10,17:1
14Clinical significance and prognostic value of CA72-4 comp ared with CEA and CA19-9 in patients with colon cancer 显示文摘Ychou M Duffour J Kramar A 2000Dis Markers2000,,:1
15Tritherapy with fluo- rouraeil/leucovorin, irinotecan and oxaliplatin (FOLFIRI- NOX): a phase II study in eoloreetal Cancer patients with non-resectable liver metastases显示文摘Ychou M Viret F Kramar A 2008Cancer Chemother Phar- maeol2008,62,2:1
16Clinical significance and prognostic value of CA724 compared with CEA and CA199 in patients with gastric cancer显示文摘YCHOU M DUFFOUR J KRAMAR A 2000Disease Markers2000,16,:1
17Single nucleotide poly- morphisms, apoptosis, and the development of severe late adverse effects after radiotherapy显示文摘Azria D Ozsahin M Kramar A 2008Clin Cancer Res2008,14,19:1
18Plasma-Replacement Technology of ETC-Ignition of Powder Charges in High-Velocity Launchers显示文摘SINYAEV S V KRAMAR M A KULPIN V I 2006IEEE Transaction on Magnatics2006,42,1:1
19Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer显示文摘Ychou M Duffour J Kramar A 2000Dis Markers2000,16,34:1
20Tritherapy with fluorouracil/leucovorin, irlnotecan and oxaliplatin (FOLFIRINOX) : a phase Ⅱ study in colorectal cancer patients with non-resectable liver metastases 显示文摘Ychou M Viret F Kramar A 2007Cancer Chemother Pharmacol2007,,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费